Search results for: 'User and Entity Behaviour Analytics Based on Machine Learning'

13 Jun 2023  |  North America  |  Market Research

US Healthcare Data Analytics, 2023

Competitive Intensity is Driving Innovation Among Healthcare Data Analytics Vendors

Infographics

×

This report offers a comprehensive analysis of the US healthcare data analytics market. The analysis focuses on solutions for payers and providers (including physician practices and hospitals). Solutions for the life sciences segment, pharmaceutical companies, and the public sector have been excluded. This study categorizes healthcare data analytic...

19 Aug 2022  |  North America  |  Frost Radar

Frost Radar™: Healthcare Data Analytics, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Healthcare organizations must be able to manage, analyze, and interpret data in order to identify strategic, tactical, and operational insights for decision making. This allows providers and payers to provide the best ways of delivering high-quality care. There has been a slow but steady change in the healthcare industry at the very core of its bus...

The value-based care (VBC) model aims to offer better outcomes and care quality to patients cost-effectively. Multiple stakeholders, including payers, healthcare providers, and medical technology (medtech) players, can share the revenue risk and incentive for providing better value. The United States is a pioneer in VBC adoption, followed by countr...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

In November 2013, Frost & Sullivan conducted an online survey, followed by a live focus group comprising C-suite executives from leading commercial healthcare payer organizations across the United States. The goal was to gain insights into how the health insurance industry approaches the use of analytics solutions going into 2014. For research purp...

This study examines the key trends and issues affecting the U.S. hospital health data analytics market, including a review of industry challenges and market drivers and restraints through 2016. It also analyzes the impact of recent legislative mandates on the implementation and usage of information technology, including data analytics, in U.S. hos...

Biomarker Analytics has always been one of the most in-demand branches of science relevant to the process of drug discovery and development in the Pharmaceutical Industry. Over the years several advances have been made in the area of biomarker analytics with the aim to accelerate the drug development process. The use of AI-based technology can incr...

Over the last 3-5 years, growing cost pressure on healthcare and pharmaceutical companies and a significant shift towards outcome based healthcare approach have resulted in companies increasingly adopting real world data and evidence solutions to optimize their operation and cost using analytics. Earlier, applications of RWE were largely limited to...

According to the Centers for Medicare and Medicaid Services (CMS), value-based care (VBC) programs reward healthcare providers with incentive payments for the quality of care they provide Medicare patients. These programs are part of its larger CMS quality strategy to reform healthcare delivery and payment. Value-based programs support 3 aims: b...